Clinicolaboratory study of mother-to-neonate transmission of hepatitis E virus in Egypt

American Journal of Clinical Pathology

Volumn 140, Issue 5, 2013, Pages 721-726

  El Sayed Zaki, Maysaa ^a   El Aal, Amena Abd ^a   Badawy, Ahmed ^a   El Deeb, Douaa Raafat ^a   El Kheir, Nermin Youssef Abo ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Gynecological; Infectious diseases; Obstetric and perinatal; Pediatrics

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HEPATITIS E ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL LABORATORY; CONGENITAL INFECTION; CONTROLLED STUDY; EGYPT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS E; HEPATITIS E VIRUS; HEPATOSPLENOMEGALY; HUMAN; HYDRAMNIOS; HYPERTRANSAMINASEMIA; LIVER FUNCTION TEST; NEWBORN; OLIGOHYDRAMNIOS; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; RECURRENT ABORTION; RESPIRATORY DISTRESS SYNDROME; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VERTICAL TRANSMISSION; VIREMIA; VIRUS TRANSMISSION;

GYNECOLOGICAL; INFECTIOUS DISEASES; OBSTETRIC AND PERINATAL; PEDIATRICS;

ADULT; ANTIGENS, VIRAL; EGYPT; FEMALE; HEPATITIS E; HEPATITIS E VIRUS; HEPATOMEGALY; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MATERNAL-FETAL EXCHANGE; MOTHERS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREMATURE BIRTH; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SEPSIS; SPLENOMEGALY;

EID: 84886247588     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPT55TDMJNPLLV     Document Type: Article

References (37)

1. Chandra V, Taneja S, Kalia M, et al. Molecular biology and pathogenesis of hepatitis E virus. J Biosci. 2008;33:451-464.
2. Fix AD, Abdel-Hamid M, Purcell RH, et al. Prevalence of antibodies in young adults in Israel: implications for the new hepatitis A vaccines. Int J Epidemiol. 2000;21:136-141.
3. Stoszek SK, Abdel-Hamid M, Saleh DA, et al. High prevalence of hepatitis E antibodies in pregnant Egyptian women. Trans R Soc Trop Med Hyg. 2006;100:95-101.
4. Adjei AA,Tettey Y, Aviyase JT, et al. Hepatitis E virus infection is highly prevalent among pregnant women in Accra, Ghana. Virol J. 2009;6:108.
5. Aggarwal R. Hepatitis E and pregnancy. Indian Gastroenterol. 2007;26:3-5.
6. Banait VS, Sandur V, Parikh F, et al. Outcome of acute hepatic failure due to acute hepatitis E in pregnant women. Indian J Gastroenterol. 2007;26:6-10.
7. Bonney JH, Kwame-Aryee RA, Obed S, et al. Fatal hepatitis E viral infection in pregnant women in Ghana: a case series. BMC Res Notes. 2012;5:478.
8. Huang FF, Haqshenas G, Guenette DK, et al. Detection by reverse transcription-PCR and genetic characterization of field isolates of swine hepatitis E virus from pigs in different geographic regions of the United States. J Clin Microbiol. 2002;40:1326-1332.
9. Choi IS, Kwon HJ, Shin N-R, et al. Identification of swine hepatitis E virus (HEV) and prevalence of anti-HEV antibodies in swine and human populations in Korea. Clin Microbiol. 2003;41:3602-3608.
10. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature. 1989;339:237-238.
11. Kumar RM, Uduman S, Rana S, et al. Sero-prevalence and mother-to-infant transmission of hepatitis E virus among pregnant women in the United Arab Emirates. Eur J Obstet Gynaecol Reprod Biol. 2001;100:9-15.
12. Singh S, Mohanty A, Joshi YK, et al. Mother-to-child transmission of hepatitis E virus infection. Indian J Pediatr. 2003;70:37-39.
13. Khuroo MS, Kamili S, Khuroo MS. Clinical course and duration of viremia in vertically transmitted hepatitis E virus (HEV) infection in babies born to HEV-infected mothers. J Viral Hepat. 2009;16:519-523.
14. Khuroo MS, Kamchi S, Jameel S. Vertical transmission of hepatitis E virus. Lancet. 1995;345:1025-1026.
15. Tsega E, Krawezynski K, Hansson BG, et al. Hepatitis E virus infection in pregnancy in Ethiopia. Ethiopian Med J. 1993;31:173-181.
16. Erlinger S. Hepatitis E virus infection: hepatitis outbreaks [in French]. Presse Med. 1997;26:422-423.
17. Bansal J, He J, Yarbough PO, et al. Hepatitis E virus infection in eastern India. Am J Trop Med Hyg. 1998;59:258-260.
18. Hamid SS, Jafri SM, Khan H, et al. Fulminate hepatic failure in pregnant women: acute fatty liver or acute viral hepatitis. J Hepatol. 1996;25:20-27.
19. Khuroo MS, Teli MR, Skidmore S, et al. Incidence and severity of viral hepatitis in pregnancy. Am J Med. 1981;70:252-255.
20. Merle P, Zoulin F, Trepo C. Hepatitis B virus infection. In: Knawy BA, Shiffman ML, Weisner RH, eds. Hepatology: A Practical Approach. San Diego, CA: Elsevier; 2004:67-86.
21. Kamili S. Immunity to hepatitis E virus: new insights and future challenges. Indian J Gastroenterol. 2002;21:136-138.
22. Khuroo MS, Kamili S. Association of severity of hepatitis E virus infection in the mother and vertically transmitted infection in the fetus. JK Pract. 2006;13:70-74.
23. Khuroo MS, Khuroo M. Association of severity of HEV infection in the mother and vertically transmitted infection in fetus [letter]. Ann Intern Med. 2007;147:33.
24. Arankalle VA, Chadha MS, Tsarev SA, et al. Seroepidemiology of water-borne hepatitis in India and evidence for a third enterically transmitted hepatitis agent. Proc Natl Acad Sci U S A. 1994;91:3428-3432.
25. Khuroo MS, Kamili S, Dar MY, et al. Hepatitis E and longterm antibody status. Lancet. 1993;341:1355.
26. Chargelegue D, Stanley CM, O'Toole CM, et al. The absence of loss of antibodies of high affinity to human immunodeficiency virus (HIV) is associated with disease progression in HIV-1-infected patients. J Infect Dis. 1995;172:897-898.
27. Olszewska W, Obeid OE, Steward MW. Protection against measles virus-induced encephalitis by anti-mimotope antibodies: the role of antibody affinity. Virology. 2000;272:98-105.
28. Tsarev SA, Tsareva TS, Emerson SU, et al. Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci U S A. 1994;91:10198-10202.
29. Arankalle VA, Chadha MS, Chobe LP. Long-term serological follow up and cross-challenge studies in rhesus monkeys experimentally infected with hepatitis E virus. J Hepatol. 1999;30:199-204.
30. Purcell RH, Nguyen H, Shapiro M, et al. Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine. Vaccine. 2003;21:2607-2615.
31. Bryan JP, Tsarev SA, Iqbal M, et al. Epidemic hepatitis E in Pakistan: patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease. J Infect Dis. 1994;170:517-521.
32. Shrestha MP, Scott RM, Joshi DM, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med. 2007;356:895-903.
33. Shata MT, Daef EA, Zaki ME, et al. Protective role of humoral immune responses during an outbreak of hepatitis E in Egypt. Trans R Soc Trop Med Hyg. 2012;106:613-618.
34. Bottiger B, Jensen IP. Maturation of rubella IgG avidity over time after acute rubella infection. Clin Diagn Virol. 1997;8:105-111.
35. Delgado MF, Coviello S, Monsalvo AC, et al. Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease. Nat Med. 2009;15:34-41.
36. Eldin SS, Seddik I, Daef EA, et al. Risk factors and immune response to hepatitis E viral infection among acute hepatitis patients in Assiut, Egypt. Egypt J Immunol. 2010;17:73-86.
37. Pal R, Aggarwal R, Naik SR, et al. Immunological alterations in pregnant women with acute hepatitis E. J Gastroenterol Hepatol. 2005;20:1094-1101.